Quantifying the effectiveness of betaherpesvirus-vectored transmissible vaccines.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 35046024.
- Also identified by DOI 10.1073/pnas.2108610119 and PMC identifier 8794881.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Transmissible vaccines have the potential to revolutionize how zoonotic pathogens are controlled within wildlife reservoirs. A key challenge that must be overcome is identifying viral vectors that can rapidly spread immunity through a reservoir population. Because they are broadly distributed taxonomically, species specific, and stable to genetic manipulation, betaherpesviruses are leading candidates for use as transmissible vaccine vectors. Here we evaluate the likely effectiveness of betaherpesvirus-vectored transmissible vaccines by developing and parameterizing a mathematical model using data from captive and free-living mouse populations infected with murine cytomegalovirus (MCMV). Simulations of our parameterized model demonstrate rapid and effective control for a range of pathogens, with pathogen elimination frequently occurring within a year of vaccine introduction. Our results also suggest, however, that the effectiveness of transmissible vaccines may vary across reservoir populations and with respect to the specific vector strain used to construct the vaccine.
Medical subject headings
- Betaherpesvirinae
- Genetic Vectors
- Immunogenicity, Vaccine
- Models, Theoretical
- Nucleic Acid-Based Vaccines
- Vaccines